The Role of Resilience for Physical Functioning of Patients With Fibromyalgia Syndrome Using the 6-Min Walk Test

Fibromyalgia (FM) is a prevalent chronic pain disorder, characterized by widespread musculoskeletal pain and fatigue that is associated with significant functional limitations. Its mechanisms are only partially understood. The investigators hypothesize that physical functioning (as measured by the 6-Min Walk Test) of FM patients and healthy controls is negatively influenced by resilience and pain sensitivity. The investigators will perform a case control study to test our hypothesis within and between groups.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Fibromyalgia Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neuromuscular Diseases Physical Function Rheumatic Diseases Six-minute Walk Test

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ages 18-70
Fulfills the 1990 and 2011 American College of Rheumatology Criteria for FM
Healthy volunteers: No significant pain

Exclusion criteria

Uncontrolled diabetes
Cancer
Uncontrolled coronary syndromes
Peripheral neuropathies
Unwillingness/inability to discontinue analgesics, hypnotics, anxiolytics, or stimulants

Treatment and study plan

Primary outcomes

Resilience score

Time frame: Through study completion (one visit - approx. 2 hours)

The Brief Resilience Scale (BRS) is a self-report measure designed to assess an individual's ability to bounce back or recover from stress, adversity, and challenging life circumstances (Smith et al., 2008) scored ranging 6-30.
Performance in 6MWT

Time frame: Through study completion (one visit - approx. 2 hours)

The total walking distance in the 6MWT is a measurement of how far an individual is able to walk (measured in meters, using a marked 30m hallway) within a 6 minute time period after being instructed to walk as far possible.

Study contacts

Contact information is provided by the study sponsor or research team.

Melyssa Godfrey, BS

CONTACT

[email protected]

352-265-8901

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Registry information

Acronym: 6MWT

Important dates

Study start: 2026
Primary completion: 2030
Study completion: 2031
First posted: May 28, 2026
Registry last updated: Jul 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed